Can Chocolate Support Cardiovascular Longevity? – Joseph Raffaele Discusses COSMOS Trial
Joseph Raffaele, Physician-Scientist in Longevity Medicine, CEO of PhysioAge LLC, posted on LinkedIn:
”Can chocolate support cardiovascular longevity?
One of the largest nutrition trials may surprise you:
Between 2014 and 2020, researchers at Brigham and Women’s Hospital led one of the largest nutrition trials ever conducted: 21,442 adults, mean age 70 years, men and women, randomised to receive either cocoa extract or placebo.
Investigators measured key markers of “inflammaging” – the chronic, low-grade inflammation that accelerates vascular and metabolic decline.
The results:
- hsCRP decreased by 8.4% per year versus placebo
- IFN-γ increased by 6.8% per year
- No significant effects were seen for IL-6, TNF-α, or IL-10
In the parent COSMOS trial, the same cocoa extract was associated with a 27% reduction in cardiovascular disease mortality, and this new data begins to explain why.
By lowering hsCRP, cocoa flavanols appear to improve the inflammatory burden that drives endothelial aging, thereby improving nitric oxide production and vascular flexibility.
The IFN-γ increase, though small, is intriguing.
It suggests a possible maintenance of antiviral and anti-tumour defences while dampening chronic inflammation.
Nutritional interventions like cocoa flavanols, polyphenols, and omega-3s are emerging as safe, evidence-based tools for modulating immune and inflammatory response.
When standardised and quantified, they extend well beyond “dietary advice.”
They influence biological pathways that drugs like statins or rapamycin target, but through gentler, everyday mechanisms.
Studies like this remind us that the most familiar molecules – flavanols, polyphenols, micronutrients – can improve cardiovascular physiology and longevity.
How do you see the balance between lifestyle and pharmacology shaping the next decade of longevity care?
Reference here.”
Title: Effects of 2-year cocoa extract supplementation on inflammaging biomarkers in older US adults: findings from the COcoa Supplement and Multivitamin Outcomes Study randomised clinical trial
Authors: Sidong Li, Rikuta Hamaya, Haidong Zhu, Allison Clar, Pamela M Rist, Ying Huang, JoAnn E Manson, Howard D Sesso, Yanbin Dong
Stay informed with Hemostasis Today.
-
May 22, 2026, 13:53Masoabi Sefojane: The Structural Invisibility of Bleeding Disorders in the Global South
-
May 22, 2026, 13:41Ney Carter Borges: New Trial Highlights IVL as Effective Strategy for Calcified Coronary Lesions
-
May 22, 2026, 13:36Ajay Samkaria։ A Compatible Crossmatch Does Not Always Mean Complete Safety
-
May 22, 2026, 13:31Mariam Swidan: Why Hemolysis Severity Matters in G6PD Deficiency
-
May 22, 2026, 13:25Augustina Isioma Ikusemoro: Why Plasma and RBC Transfusions Follow Different Compatibility Rules
-
May 22, 2026, 13:08Anas Hamad: Thrombosis as Overlooked Clinical Challenge in APL
-
May 22, 2026, 12:29Neema Ngugi: Highlighting 6 Major Types of Anemia
-
May 22, 2026, 12:27Jacinto López Sagaseta: Solving the Structural Puzzle of FVIIa–EPCR Interaction
-
May 22, 2026, 12:25Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms